4.5 Article

Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 112, 期 8, 页码 2057-2068

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2022.12.019

关键词

Grazoprevir; Co-precipitation; Co-precipitated amorphous dispersion; Amorphous; cPAD; Particle engineering; Co-processed API

向作者/读者索取更多资源

Co-precipitation is examined as a novel manufacturing approach for amorphous solid dispersions (ASDs) and its impact on processing conditions, surface composition, and release performance is evaluated. Hierarchical particles with an additional water soluble component coating the surfaces of core ASD particles were successfully created. It was found that cPAD particles with lower surface drug concentration exhibited improved release compared to particles with higher surface drug concentration.
Co-precipitation is an emerging manufacturing strategy for amorphous solid dispersions (ASDs). Herein, the interplay between processing conditions, surface composition, and release performance was evaluated using grazoprevir and hypromellose acetate succinate as the model drug and polymer, respectively. Co -precipitated amorphous dispersion (cPAD) particles were produced in the presence and absence of an additional polymer that was either dissolved or dispersed in the anti-solvent. This additional polymer in the anti -solvent was deposited on the surfaces of the cPAD particles during isolation and drying to create hierarchical particles, which we define here as a core ASD particle with an additional water soluble component that is coating the particle surfaces. The resultant hierarchical particles were characterized using X-ray powder diffraction, differential scanning calorimetry, scanning electron microscopy, and X-ray photoelectron spectroscopy (XPS). Release performance was evaluated using a two-stage dissolution test. XPS analysis revealed a trend whereby cPAD particles with a lower surface drug concentration showed improved release relative to particles with a higher surface drug concentration, for nominally similar drug loadings. This surface drug concentration could be impacted by whether the secondary polymer was dissolved in the anti-solvent or dispersed in the anti-solvent prior to isolating final dried hierarchical cPAD powders. Grazoprevir exposure in dogs was higher when the hierarchical cPAD was dosed, with & drangbrac;1.8 fold increase in AUC compared to the binary cPAD. These observations highlight the important interplay between processing conditions and ASD performance in the context of cPAD particles and illustrate a hierarchical particle design as a successful approach to alter ASD surface chemistry to improve dissolution performance. & COPY; 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据